- Lobbying
- Lobbying by Burson Cohn & Wolfe on behalf of AstraZeneca Pharmaceuticals LP
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Emily Katz | 2013-15: Senior Health Policy Advisor, Sen. Barbara Boxer; 2010-13: Health Policy Director, Rep. Diana DeGette; 2009-10: Legislative Assistant, Sen. Ron Wyden; 2005-07: Legislative Aide, Sen. Ron Wyden; 2004: Biomedical Ethics Intern (Paid), NIH |
Rich Meade | 1994-96: Legislative Director, Rep. Jim Nussle; 1997-2003: Chief of Staff, Rep. Jim Nussle; 2001-05: Chief of Staff, Committee on the Budget, House of Representatives |
Mitchell Vakerics | 2007-08: Staff Assistant, Rep. Timothy Murphy; 2008-09: Legislative Correspondent/Press Assistant, Rep. Timothy Murphy; 2011-15: Legislative Counsel, Rep. Renee Ellmers; 2015: Legislative Director, Rep. Renee Ellmers |
Martin Paone | 1995-2001: Secretary for the Minority, Senate; 2001-2002: Secretary, Majority, Senate; 2002-2007: Secretary, Minority, Senate; 2007-2008: Secretary, Majority, Senate; 2015-2017: Deputy Assistant to the President for Legislative Affairs, White House |
Aquila Powell | 1996-1999: Legislative Aide, US Senator Herb Kohl (D-WI); 1994-1995: Legislative Correspondent, Rep. John Bryant (D-TX); 1999-2001: Special Assistant, Office of the Assistant Secretary for Legislation |
R Scott Pastrick | n/a |
Charles Black | n/a |
Mark Disler | n/a |
R. Scott Pastrick | n/a |
Becky Weber | n/a |
Casie Daugherty | n/a |
Stefan Bailey | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
White House Office
Health & Human Services - Dept of (HHS)
State - Dept of (DOS)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
White House Office
Health & Human Services - Dept of (HHS)
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Registration
Issue(s) they said they’d lobby about: COVID-19 vaccine and therapy development.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate